Neuroendocrine tumours: An update about diagnosis and treatment;Tumori neuroendocrini: Linee guida per la diagnosi e il trattamento

European Journal of Oncology

Volumn 9, Issue 1, 2004, Pages 37-47

  Cirillo, Fernando ^a  

^a CREMONA HOSPITAL   (Italy)

Author keywords

Carcinoid; Merkel cell carcinoma; Neuroendocrine tumours; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA INTERFERON; ANGIOPEPTIN; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; LOMUSTINE; MELPHALAN; METHOTREXATE; OCTREOTIDE; PENTETREOTIDE IN 111; PREDNISONE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; VAPREOTIDE; VINCRISTINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DIAGNOSTIC IMAGING; GENETIC ANALYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MERKEL CELL TUMOR; METASTASIS POTENTIAL; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PHYSICAL DISABILITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RADIOFREQUENCY; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

EID: 2542460133     PISSN: 11286598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. De Angelis C, Tesio L, Rizzetto M, et al. Tumori neuroendocrini non pancreatici (parte 1) Banca Dati sulle Malattie Endocrine Gastroenteropancreatiche (Progetto GEP). Milano: Excerpta Medica, 2002.
2. De Angelis C, Tesio L, Rizzetto M, et al. Tumori neuroendocrini pancreatici (parte 2) Banca Dati sulle Malattie Endocrine Gastroenteropancreatiche (Progetto GEP). Milano: Excerpta Medica, 2002.
3. Ambrosi A, Iacobone M, Ferini A, et al. Epidemiologia dei tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed. Milano: Casa Editrice Ambrosiana, 2001, 1-19.
4. Cirillo F. Clinica e fisiopatologia del tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed. Milano: Casa Editrice Ambrosiana, 2001,75-104.
5. Cirillo F. Lo screening territoriale delle neoplasie GEP: esperienza e prospettive. In Lombardi L. I tumori neuroendocrini gastroenteropancreatici: inquadramento clinico e prospettive terapeutiche. Roma: Mediprint, 1999, 42-44.
6. Seregni E, Ferrari L, Stivanello M, et al. Laboratory tests for neuroendocrine tumours. Q J Nucl Med 2000; 44: 22-41.
7. Prinz RA, Marangos PJ. Use of neurospecific enolase as a serum marker for neuroendocrine neoplasms. Surgery 1982; 92: 887-9.
8. Krudy AG, Doppman JL, Jensen RT, et al. Localization of islet cell tumours by dynamic CT: comparison with plain CT, arteriography, sonography and venous sampling. Am J Roentgenol 1984; 143: 585-89.
9. Van Hoe L, Gryspeerdt S, Marchal G, et al. Helical CT for the preoperative localization of islet cell tumours of the pancreas: value of arterial and parenchimal phase images. Am J Roentgenol 1995; 165: 1437-9.
10. Chung MJ, Chol BI, Han JK, et al. Functioning islet cell tumor of the pancreas. Localization with dynamic spiral CT. Acta Radiol 1997; 38: 135-38.
11. Ichikawa T, Peterson MS, Federle MP, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 2000; 216: 163-71.
12. Van Hoe L, Gryspeerdt S, Baert AL. Functioning endocrine tumours of the pancreas: comparison of single-shot MRI and dual-phase helical CT. Eur Radiol 1997; 7: S142.
13. De Angeli C, Carucci P, Malcotti C, et al. Ruolo del'ecoendoscopia nella localizzazione delle neoplasie neuroendocrine gastroenteropancreatiche. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 201-15.
14. Lima GF. Ruolo degli analoghi radiomarcati della somatostatina nella diagnosi dei tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 217-44.
15. Termanini B, Gibril F, Reynolds JC, et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997; 112: 335-47.
16. Cadiot G, Bonnaud G, Lebtahi R, et al. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Gut 1997; 41: 107-14.
17. Lebtahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumours. J Nucl Med 1997; 38: 853-8.
18. Chiti A, Fanti S, Savelli G, et al. Comparison of somatostain receptor imaging, computer tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 1998; 25: 1396-403.
19. 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Q J Nucl Med 2000; 44: 77-87.
20. Eriksson B, Bergström M, Örlefors H, et al. Use of PET in neuroendocrine tumours: in vivo applications and in vivo studies. Q J Nucl Med 2000; 44: 68-76.
21. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours. In WHO International histological classification of tumours. Berlin Heidelberg: Springer-Verlag, 2000.
22. Cirillo F. Trattamento dei tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 293-344.
23. Morelli A, Falchetti A, Brandi ML. I tumori neuroendocrini gastroenteropancreatici nell'ambito delle neoplasie endocrine multiple. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 123-32
24. Volpi D, Meroni L, Rozzi G, et al. Diagnostica per immagini dei tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 155-200.
25. Falconi M, Bettini R, Salvia R, et al. Trattamento chirururgico dei tumori neuroendocrini del pancreas. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 345-63.
26. Perry LJ, Stuart K, Stokes KR, et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumours. Surgery 1994; 116: 1111-7.
27. Cantore M, Zamagni D, Rozzi G. Il trattamento loco-regionale delle endocrinopatie del tratto digestivo. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 387-404
28. McEntee GP, Nagomey MD, Kvols LK, et al. Cytoreductive hepatic surgery for neuroendocrine tumours. Surgery 1990; 108 (6): 1091-6.
29. Carty SE, Jensen RT, Norton JA. Prospective study of aggressive resection of metastatic pancreatic endocrine tumours. Surgery 1992; 112 (6): 1024-32.
30. Norton JA. Surgical management of carcinoid tumours: role of debulking and surgery for patient with advanced disease. Digestion 1994; 55 (3): 98-103
31. Falconi M, Bonora A, Bassi C, et al. Non-functioning pancreatic endocrine tumours. In Dervenis CG, Bassi C. Pancreatic tumours. Stuttgard: Thieme Verlag, 2000, 54-61.
32. Modlin IM, Schmid SW, Tang LH, et al. Endocrine tumours of the pancreas. In Dervenis CG, Bassi C. Pancreatic tumours. Stuttgard: Thieme Verlag, 2000, 332-53.
33. Skogseid B. Multiple endocrine neoplasia type I. Clinical genetics and diagnosis. In Arnold A. Endocrine neoplasms. Boston: Kluwer Academic Publishers; 1997, 383-406.
34. Ahlman H, Kölby L, Lundell L, et al. Clinical management of gastric carcinoid tumours. Digestion 1994; 55 (3): 77-85.
35. Åkerström G. Management of carcinoid tumours of the stomach, duodenum and pancreas. World J Surg 1996; 20: 173-82.
36. Åkerström G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumours. Acta Oncol 1991; 30: 547-53
37. Box JC, Watne AL, Lucas GW. Small bowel carcinoid: review of a single institution experience and review of the literature. Am Surg 1996; 62: 280-6.
38. Öhrvall U, Eriksson B, Juhlin C, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumours. World J Surg 2000; 24: 1402-8.
39. Galland RB, Blumgart LH. Carcinoid syndrome: surgical management. Br J Hosp Med 1986; 35: 166-70.
40. Stinner B, Kisker O, Zielke A, et al. Surgical management for carcinoid tumours of small bowel, appendix, colon, and rectum. World J Surg 1996; 20: 183-8.
41. Basson MD, Ahlman H, Wängberg BO, et al. Biology and management of the midgut carcinoid. Am J Surg 1993; 165: 288-97.
42. Kenady DE, Mc Grath PC, Sloan DA, et al. Diagnosis and management of pheochromocytoma. Curr Op Onc 1997; 9: 61-7.
43. Nathu RM, Mendenhall WM, Parson JT. Merkel cell carcinoma of the skin. Rad Oncol Invest 1998; 6: 233-9.
44. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134: 388-93.
45. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoidi tumours of the lung. J Thorac Cardiovasc Surg 1972; 64: 413-21.
46. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumours of the lung with proposed criteria for large cell neuroendocrine carcinoma. An-ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am Surg Pathol 1991; 5: 529-53.
47. Kvols LK. The carcinoid syndrome: a treatable malignant disease. Oncology (Williston Park) 1988; 2: 33-41.
48. Pass HI, Doppman JL, Nieman L, et al. Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann Thorac Surg 1990; 50: 52-7.
49. Capella C, Heits PU, Höfler H, et al. Revised classification of neuroendocrine tumours of the lung pancreas and gut. Virchous Arch 1995; 425: 547-60.
50. Vadasz P, Palffy G, Egervary M, et al. Diagnosis and treatment of bronchial carcinoid tumours: clinical and pathological review of 120 operated patients. Eur J Cardiothorac Surg 1993; 7: 8-11.
51. Dusmet M, Kneally MF. Bronchial and thymil carcinoid tumours: a review. Digestion 1994; 55: 70-6.
52. Hammond ME, Sause WT. Large cell neuroendocrine tumours of the lung. Clinical significance and histopathologic definition. Cancer 1985; 56: 1624-9.
53. Colby TV, Koss MN, Travis WD. Small cell carcinoma and large cells neuroendocrine carcinoma. Atlas of Tumor Pathology. Tumours of the Lower Respiratory Tract, 3rd ed, fascicle 13. Washington: Armed Forces Institute of Pathology, 1980
54. Cirillo F, Bottini A, Lima G, et al. Chirurgia radioguidata nel trattamento dei tumori neuroendocrini gastroenteropancreatici. Minerva Chir 2000; 55: 517-21.
55. Moertel GC, Kvols LK, O'Connell MJ, et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 1991; 68: 227-32.
56. Seitz JF, Perrier H, Giovannini M, et al. Cancers neuroendocrines anaplasiques avancés: intérêt de l'association VP16-CDDP. Bull Cancer 1995; 82: 433-44.
57. Yakendji K, Ducreux M, Duviliard P, et al. L'efficacité de l'association etoposide (VP16) et cisplatinum (CDDP) dans les tumeurs neuroendocrines (TNE) peu différenciées d'origine digestive. Bull Cancer 1995; 82: 433-8.
58. Mitry E, Baudin E, Ducreux M, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81 (8): 1351-5.
59. Cirillo F. Neuroendocrine gastroenteropancreatic tumours: 11 years of clinical experience. Intl J Med Biol Environ 2001; 29 (2): 129-41.
60. Artale S, Bajetta E, Buzzoni R, et al. Tumori neuroendocrini del polmone. Argomenti di Oncologia 1999; 20: 369-72.
61. Letizia C, Scuro L, Cerci S. Feocromocitoma. In Andreani D, Tamburrano G. Manuale di terapia delle malattie endocrine e metaboliche. Roma: Antonio Delfino Editore, 2000, 225-34.
62. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85: 2589-95.
63. Cirillo F, Filippini L, Lima GF, et al. Tumore a cellule di Merkel: segnalazione di un caso e trattamento con octreotide. Minerva Chir 1997; 52: 1359-65.
64. Cirillo F, Buononato M, Lima GF, et al. Clinical experience on eight cases of Merkel cell carcinoma. Tumori 2003; 89: 146-51.
65. Debas HT, Gittes G. Somatostatin analogue therapy in functioning neuroendocrine gut tumours. Digestion 1993; 54 (1): 68-71.
66. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocrine Rev 1991; 12 (4): 450-82.
67. Anthony L, Johnson D, Hande K, et al. Somatostatin analogue phase I trial neuroendocrine neoplasms. Acta Oncol 1993; 32: 217-23.
68. Chiti A. La terapia radiometabolica nei tumori neuroendocrini gastroenteropancreatici. In Cirillo F. I tumori neuroendocrini gastroenteropancreatici. Manuale di diagnosi e trattamento, 3° ed, Milano: Casa Editrice Ambrosiana, 2001, 405-15.